The protocol describes a quantitative RT-PCR method for the detection and quantification of EHV-2 in equine respiratory fluids according to the NF U47-600 norm. After the development and first validation step, two distinct characterization steps were performed according to the AFNOR norm: (a) characterization of the qRT-PCR assay alone and (b) characterization of the whole analytical method. The validation of the whole analytical method included the portrayal of all steps between the extraction of nucleic acids and the final PCR analysis.
Introduction
Equid herpesvirus-2 (EHV-2) is involved in a respiratory syndrome, with potential clinical manifestations such as nasal discharge, pharyngitis and swollen lymph nodes [1] [2] [3] . This virus is also suspected to be associated with the poor-performance of horses, which may result in a significant and negative economic impact for the horse industry 2 .
Until now, the gold standard for gamma-EHV (γ-EHV) detection was the cell culture method. The first inconvenience of this procedure was the absence of discrimination between EHV-2 and other γ-EHV's (e.g., EHV-5). The second inconvenience was the slow development of the cytopathic process, which takes from 12 to 28 days to manifest 4, 5 . Development of a validated and normalized quantitative real-time polymerase chain reaction (qRT-PCR) method will help to rapidly detect the virus, to discriminate between EHV-2 and EHV-5 and to study the relationship between the viral genome load and the disease thanks to the quantification aspect.
Polymerase chain reaction (PCR) was described for the first time in 1986 by Mullis 6 and is about to become the new gold standard in most of the fields of biological diagnosis (human, environment and veterinary). This method, which is based on the amplification of a part of the genome of pathogens, presents many advantages: specificity, sensitivity and rapidity. Moreover, the risk of amplicon contamination receded since the advent of qRT-PCR and quality assurance
Characterization of the Whole Analytical Method (from DNA Extraction to the qRT-PCR Result)
Note: The characterization of the whole method is the validation of all steps necessary to obtain qRT-PCR data (i.e., from the extraction of DNA from the respiratory sample (see section 1) to the amplification and quantification of the target (see section 2)).
1. Establish correspondence between the copies number in the PCR reaction and the copies number present in the biological sample with the formula:
.
The is the number of plasmid copy in the PCR reaction, is the volume of sample added to PCR mix for amplification, is the volume of Buffer AVE used to elute nucleic acids and is the volume of the extracted sample.
Test the Sensitivity and Specificity of the Whole Analytical Method
Note: Only known EHV-2 positive (or negative) samples are used in this section.
4. Calculate the 95% confidence interval for sensitivity and specificity of the whole method with the formula of Greiner and Gardner relation 12, 20 :
where e is the estimated error, θ is the Se (or Sp) and n the number of samples analyzed. Note: For a small number of samples, use the Schwartz 2 until the last tube in the serial dilution has received plasmid. 3. Transfer 5 µl from each dilution of plasmid to 2 tubes with 135 µl of the negative resource material to obtain 2 replicates for the 6 positive standards. Vortex and briefly centrifuge. 4. Perform extraction of the 2 replicates for the 6 positive standards as described in section 1. Perform the amplification procedure as described in section 2. 5. Determine the abatement zone: the zone between the last concentration of plasmid giving a positive signal and the first concentration that shows no signal.
Limit of Detection of the Method (LOD Method ) Determined by 2 Independent Trials
Note: Perform 2 independent trials to determine the limit of detection of the whole method (LOD Method ). 1. Start the 6 two-fold serial dilutions with the plasmid working dilution that is 4 times more concentrated that the last concentration of the plasmid that gave a positive signal (see section 5.4.1.5). 
Linearity Range and Limit of Quantification of the Whole Analytical Method
Note: To determine the limit of quantification of the whole method (LOQ Method ), add known concentrations of the plasmid to biological samples that are known to be free of the target (EHV-2 in this case). These samples constitute positive standards to determine the LOQ Method . 
Representative Results
The quantitative RT-PCR method, as described above, was implemented to detect and quantify equid herpesvirus-2 in respiratory fluids. Figure  1 illustrates a schematic workflow chart for the development and validation of a quantitative RT-PCR method according to the AFNOR norm NF U47-600. Specificity of the primers and probes were validated during the step-by-step development of the PCR. Only EHV-2 strains were amplified in this system. Subsequently, the performance of the qRT-PCR had to be characterized.
Firstly, to estimate the LOD PCR , a 6 ten-fold serial dilution was performed to establish the abatement zone (Figure 2) . In this example, 6 tenfold serial dilutions were made between 10 -5 and 10 -10 (between 26,000 and 0.26 copies/2.5 µl sample) to estimate the LOD PCR . The abatement zone lies between dilutions of 10 -9 and 10 -10 (between 2.6 and 0.26 copies/2.5 µl sample). To determine the LOD PCR value in this case, 6 twofold serial dilutions of the plasmid were made in this abatement zone between 5.2 and 0.16 copies/2.5 µl sample. The LOD PCR value was 2.6 copies/2.5 µl sample.
To determine the linearity range and LOQ PCR , the LOD PCR value was used to start the range of 6 ten-fold serial dilutions, between 2.6 (LOD PCR ) and 260,000 copies/2.5 µl sample. Figure 3 illustrates a linear regression for the EHV2 qRT-PCR from one trial. The performances of linear regression (Figure 4) are validated in quadruplicate using the calculations described in Table 3 . The calculations are performed to define the linearity range according to the criteria absolute Bias i value ≤0.25 log 10 , whatever the level i of plasmid load. In this case, the linearity range lay between 2.6 and 260,000 copies/2.5 µl sample. The LOQ PCR is the lowest concentration in the linearity range (i.e., 2.6 copies/2.5 µl sample in this case). U LIN was determined to be 0.12 log 10 in the range 2.6-260,000 copies/2.5 µl of DNA.
After development (Figure 1, blue) and characterization of the qRT-PCR (Figure 1, yellow) , the AFNOR NF U47-600 norm recommends characterization of the whole analytical method from DNA extraction to qRT-PCR (Figure 1, orange) . The diagnostic sensitivity and specificity were calculated as described in Table 4 . The quantitative performances of the qRT-PCR whole analytical method was evaluated and validated with an accuracy profile (Figure 5) .
This protocol, which uses state-of-the-art molecular technology, allowed us to detect and quantify the EHV-2 viral genome load in 172 nasal swab samples obtained from horses with respiratory disorders and/or clinical suspicion of infection. The incidence of EHV-2 from field (biological) samples was 50% (86/172) in this population. The quantitative analyses showed that viral genome loads of EHV-2 were significantly higher in young horses and the repartition of viral genome loads decreased with age (Figure 6 ). In the present study, the highest EHV-2 viral genome load (1.9 x 10 11 copies/ml) was detected in foals (Figure 6 ). ). For each trial, the performances of linear regression (y = ax+b) are validated using the table where y is the cycle threshold obtained; a is the slope obtained; x is the plasmid level and b is the intercept. i is the plasmid level (i varies from 1 to k levels); k is the number of plasmid levels used (e.g, k = 6 in this table); j is the trial (j varies from 1 to I trials); I is the number of trials, comprised between 3 and 6 trials (e.g. I = 4 in this table). x i is the estimated plasmid quantity for each i plasmid level. 
Discussion
Since the 2000s, real-time PCR has been replacing gold standard techniques (cell culture and bacteria culture methods) in an increasing number of laboratories. Implementation of the technique is relatively easy. However validation of laboratory methods is essential for molecular detection and quantification of pathogens to ensure accurate, repeatable and reliable data.
Since the extraction step is the primary source of loss of biological material, it may be considered the main source of error of quantification between one protocol and another. As such, the creation of a standard curve of DNA plasmid during qRT-PCR, mainly reported in the literature, indicates the viral genome load but does not take into account the extraction step.
Description of a de novo strategy for a whole method validation process in the AFNOR norm NF U47-600-2 represents a significant progress in this area. As illustrated in this paper for EHV-2 in horses, or by others in bees 21 , this necessitates clear differentiation between the development step and the validation step with characterization of the PCR and characterization of the whole method. One limitation in this interesting approach is that any change in the protocol will result in the obligation to revalidate the complete process which could be very costly. This limitation was also highlighted by the fact that the confines of quantification depend on the source from which the virus is extracted (e.g., respiratory fluids, organs, blood or urine). In fact, each matrix presents different specificities in their physico-chemistry characteristics and it is important to define independently each different matrix used for viral detection and quantification by qRT-PCR. Thus, the viral genome load of each biological sample can be quantified more precisely from the extraction. The characterization also takes into account the thermocycler model and when the use of a previously well-characterized method (e.g., the EHV-2 qPCR method described in this paper) necessitates a new type of machine in the parent laboratory or another laboratory, one must confirm the performance of that instrument. The confirmation of the performance of a qPCR assay is a prerequisite for all tests bring into a laboratory. This is normally achieved by analyzing a reference sample with known properties. Such a check is a prerequisite and considered mandatory as requested by the NF 47-600-1 AFNOR norm in order to validate the performance of the qPCR (LOD, LOQ efficiency) and the robustness of the whole method (LOD, LOQ). Not only during the development and characterization steps but also when used in research or for diagnostic purposes, the risk factors can be identified and well controlled to ensure standardization of the protocol. Of particular concern is adequate staff training, highly qualified personnel, quality control of the consumables used and their storage, control of the immediate environmental conditions and awareness of metrological conditions that may affect the performance of the scientific instruments involved in the assay. Use of reference samples for inter-laboratory comparisons could also help control the uncertainties. In this manner, comparison of data between laboratories may be facilitated. Indeed, inter-laboratory proficiency tests are essential to evaluate and confirm the reproducibility of the method. Viral genome load results which are expressed in international units (IU) of the analyzed biological matrix (IU: copies/ml for fluids or copies/g for tissues) are easier to use in order to compare results between different laboratories. All the results above the LOQ are expressed as copies/ ml and a result between the LOD and LOQ is taken as a non-quantifiable positive result. Presenting quantificational data of the genome in this manner conforms more precisely to the process of analyses (amplification of the genome). In fact, in cell culture experiments, expression of the viral load by TCID 50 (median tissue culture infective dose) is dependent on the nature of the cells and virus strains. Each strain line possesses its unique infection kinetics and some viruses like EHV-2 can take several days before the first cytopathogenic effect is apparent.
In conclusion, this new method of characterization of qRT-PCR should facilitate the harmonization of data presentation and interpretation between laboratories. This will be very useful for potential new applications of qRT-PCR in the future like the establishment of a cut-off value for declaration of the disease status instead of merely the presence or absence of the pathogen.
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